Mrs. Xi Yang | Innovative Leadership | Best Researcher Award

Posted on by ScienceFather

Mrs. Xi Yang | Innovative Leadership | Best Researcher Award

ChongQing Academy of Animal Sciences, China

Profile

Scopus 

Early Academic Pursuits 🎓

Dr. Yang Xi’s academic journey began with a deep interest in the intersection of genetics and immunology. She obtained her undergraduate degree in biological sciences, where she excelled in courses related to microbiology, genetics, and biotechnology. This academic foundation sparked her curiosity about how organisms respond to infections and how scientific innovations could be harnessed to address global health challenges. Pursuing her graduate studies, she delved into molecular biology and genetic engineering, focusing on immune responses and pathogen interactions at the cellular level. Her early academic experiences laid the groundwork for her groundbreaking work in genetic engineering, which she would later apply to develop innovative solutions in vaccine and antibody production.

Her Ph.D. research expanded on these concepts, particularly in the realm of genetic engineering vaccines. It was during this period that Dr. Yang first discovered the potential of using genetic engineering techniques in pathogen defense. This discovery set the trajectory for her future research and cemented her position as a thought leader in the field.

Professional Endeavors 🧑‍🔬

Dr. Yang Xi’s professional career began shortly after completing her doctoral studies. She joined the Chongqing Academy of Animal Sciences as an Associate Research Fellow, where she quickly gained recognition for her expertise in genetics and immunology. As the Head of the Gene Engineering Research Group, Dr. Yang has been instrumental in steering her team toward innovative solutions for pathogen defense through cutting-edge research.

Her role at the Academy has been pivotal in both academic and applied research, where she focuses on developing genetic engineering-based vaccines and antibodies. Dr. Yang collaborates extensively with both national and international experts in the fields of microbiology, immunology, and biotechnology, ensuring that her research aligns with global scientific advancements. She has maintained a fine balance between theory and practice, turning her research into real-world applications that can make a difference in combating infectious diseases.

Contributions and Research Focus 🔬

Dr. Yang Xi’s research focuses on the crucial intersection of genetic engineering and host-pathogen interactions. Her primary goal is to understand the defense mechanisms employed by hosts when confronted with pathogen infections. This understanding enables the development of high-quality, effective vaccines and antibody therapies that are vital for disease prevention and control.

Genetic Engineering Vaccines 🦠💉

One of Dr. Yang’s key research areas is the development of genetic engineering vaccines. Her research investigates how specific anatomical sites in the host trigger immune responses when exposed to pathogens. With this knowledge, she has designed and developed various genetic engineering vaccines, which include yeast-based delivery systems. These vaccines represent a significant advancement in the field, providing a more efficient and cost-effective alternative to traditional vaccine development. Dr. Yang holds a patented technology for yeast-delivered oral subunit vaccines, which has already begun to attract attention in the scientific community for its potential to revolutionize vaccine delivery.

Genetic Engineering Antibodies 💊🧬

Another significant aspect of Dr. Yang’s research is the development of genetic engineering antibodies. Her research is guided by the specific needs of the national market, focusing on the creation of antibody drugs with enhanced functionality and compatibility. Dr. Yang’s work also extends to engineering modifications of these antibodies to optimize their therapeutic potential. Furthermore, her research is not just confined to basic studies; it integrates seamlessly with production processes to bring engineered antibodies into the pharmaceutical industry. This research has led to the development of new methods for large-scale antibody production, which are crucial for global health solutions.

Accolades and Recognition 🏆

Dr. Yang Xi has garnered widespread recognition for her innovative research and contributions to genetic engineering and immunology. Her patented technology for yeast-delivered oral subunit vaccines has been widely acknowledged as a groundbreaking achievement in the field. This work has not only contributed significantly to academic knowledge but has also positioned Dr. Yang as a leader in the field of genetic engineering vaccines.

Her achievements have earned her numerous accolades, including invitations to speak at prestigious international conferences, awards for excellence in research, and recognition from industry leaders. These accolades reflect the impact of her work in both the scientific community and the biotechnology industry, further cementing her position as an influential researcher.

Impact and Influence 🌍✨

Dr. Yang Xi’s research has had a far-reaching impact on the fields of genetic engineering, immunology, and biotechnology. Her work on genetic engineering vaccines and antibodies has the potential to address some of the world’s most pressing health challenges, including infectious diseases. By utilizing advanced genetic engineering techniques, Dr. Yang’s research contributes to the development of more effective vaccines and antibody therapies, offering hope for better disease prevention and treatment strategies.

In addition to her academic and scientific influence, Dr. Yang’s research has contributed to the training and mentorship of numerous students and researchers in the field of genetic engineering. Her leadership in the Gene Engineering Research Group has fostered a collaborative environment, enabling the development of innovative solutions to complex biological challenges.

Legacy and Future Contributions 🌱🚀

As Dr. Yang Xi continues to build upon her accomplishments, her legacy is one of innovation, dedication, and a strong commitment to improving global health. Her contributions have laid the foundation for future advancements in genetic engineering and vaccine development. Looking forward, Dr. Yang aims to further refine her yeast-based vaccine delivery systems, potentially leading to a new era in how vaccines are administered globally. Additionally, her work in the field of genetic engineering antibodies promises to transform therapeutic approaches for a variety of diseases.

In the coming years, Dr. Yang envisions expanding her research to address emerging infectious diseases and to develop solutions that can meet the evolving needs of global healthcare. With her expertise, passion for innovation, and commitment to improving health outcomes, Dr. Yang Xi is poised to make lasting contributions to the fields of immunology, biotechnology, and genetic engineering, further cementing her legacy as a pioneer in these disciplines

📝Notable Publications

High-affinity monoclonal antibodies against the porcine epidemic diarrhea virus S1 protein

Authors: Lang, Q., Huang, N., Guo, J., Ge, L., Yang, X.

Journal: BMC Veterinary Research

Year: 2024

Characterization of monoclonal antibodies against porcine epidemic diarrhea virus S1/S2 junction protein

Authors: Huang, N., Lang, Q., Li, L., Ge, L., Yang, X.

Journal: AMB Express

Year: 2023

Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid hybridoma screening and high-throughput single-cell V(D)J sequencing

Authors: Yang, X., Chi, H., Wu, M., Xia, X., Ge, L.

Journal: Frontiers in Immunology

Year: 2022

Development of an improved virus plaque assay based on avicel | 一种基于胶体微晶纤维素的改良病毒蚀斑测定法的建立与评价

Authors: Lang, Q., Huang, N., Li, L., Ge, L., Yang, X.

Journal: Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Year: 2022

Generation of fully human anti-GPC3 antibodies with high-affinity recognition of GPC3 positive tumors

Authors: Yu, L., Yang, X., Huang, N., Wang, J., Ge, L.

Journal: Investigational New Drugs

Year: 2021

Dr. Barbara Wlodarczyk | Authentic Leadership | Best Researcher Award

Posted on by ScienceFather

Dr. Barbara Wlodarczyk | Authentic Leadership | Best Researcher Award

Department of Digestive Tract Diseases, Medical University of Lodz, Poland

Profile 

Google Scholar

Early Academic Pursuits 🎓

Barbara Wlodarczyk embarked on her academic journey at the Medical University of Lodz, Poland, where she earned her medical degree (2006–2011). Her time at the university not only honed her foundational medical knowledge but also fueled her interest in gastroenterology and pancreatic diseases. Continuing her academic pursuits, Barbara joined the Department of Digestive Tract Diseases as a Ph.D. student from 2013 to 2019, where her research delved into gastrointestinal disorders, particularly focusing on pancreatic diseases and metabolic pathways. She successfully defended her thesis and was awarded a Ph.D. in medical sciences in 2021, a testament to her dedication to advancing clinical understanding in gastroenterology.

Professional Endeavors 🩺

Barbara’s professional journey is deeply rooted in her commitment to gastroenterology. From 2014 to 2022, she specialized in gastroenterology at the Department of Digestive Tract Diseases in Lodz, refining her clinical skills in diagnosing and treating complex digestive disorders. Her expertise was formally recognized in November 2022, when she earned the title of Specialist in Gastroenterology. Barbara continued her career as an assistant at the same department, contributing to the field through clinical care and active participation in teaching and research.

Contributions and Research Focus 🔬

Barbara has made significant strides in understanding pancreatic adenocarcinoma (PDAC) and chronic pancreatitis (CP). Her research explores the relationship between insulin resistance, insulin-like growth factors (IGF-1), and other biomarkers like retinol-binding protein (RBP-4). Her work aims to enhance diagnostic precision for pancreatic diseases and develop novel biomarkers to differentiate between CP and PDAC.

Her scholarly contributions are evident in her active participation in numerous conferences:

  • At Digestive Disease Week 2016 in San Diego and 2017 in Chicago, Barbara presented groundbreaking findings on IGF-1 and RBP-4.
  • Her oral presentation at the Polish Pancreatic Club (2016) and the European Pancreatic Club (2018, Berlin) showcased her leadership in translating complex data into clinical insights.
  • She also co-organized and presented at events like Juvenes pro medicine (2010–2012), fostering interdisciplinary discussions on gastrointestinal endoscopy and malignancies.

Accolades and Recognition 🏆

Barbara’s research has been recognized both nationally and internationally. Her poster presentations at prestigious platforms, including the European Pancreatic Club Annual Meetings and the Polish Society of Gastroenterology Congress, underscore her dedication to advancing pancreatic disease diagnostics.

Moreover, her efforts have gained recognition from global organizations. She was a prominent presenter at international conferences like the Digestive Disease Week in the U.S. and the European Pancreatic Club meetings in Liverpool and Berlin, solidifying her reputation as a global contributor to gastroenterology research.

Impact and Influence 🌟

Barbara’s research is pioneering the use of biomarkers like IGF-1 and IGFBP-2 in differentiating pancreatic diseases. Her work holds promise for earlier and more accurate diagnosis of pancreatic adenocarcinoma, which could lead to improved survival rates and patient outcomes. Additionally, her ability to bridge clinical practice with research ensures that her findings are directly applicable to patient care.

As an educator, Barbara actively mentors young medical professionals, sharing her expertise in gastroenterology and research methodologies. Through her organizational roles, such as coordinating the gastroenterological course on premalignant and malignant gastrointestinal images, she has contributed to enhancing medical education and interdisciplinary collaboration.

Legacy and Future Contributions 🌏

Looking ahead, Barbara Wlodarczyk aims to deepen her research into innovative diagnostic tools and personalized treatment strategies for gastrointestinal diseases. Her ongoing focus on biomarkers in pancreatic adenocarcinoma sets the stage for advancements in early detection and therapeutic interventions.

Barbara’s influence extends beyond her academic and clinical achievements, inspiring a generation of young scientists and clinicians to pursue excellence in gastroenterology. Her work represents a vital contribution to the global effort to combat pancreatic diseases and improve digestive health, ensuring a lasting legacy in medical science. 🌟

📝Notable Publications

Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC)

Authors: B Wlodarczyk, A Gasiorowska, A Borkowska, E Malecka-Panas

Journal: Pancreatology

Year: 2017

Association of genetic variants affecting microRNAs and pancreatic cancer risk

Authors: Y Lu, C Corradi, M Gentiluomo, E López de Maturana, …

Journal: Frontiers in Genetics

Year: 2021

Serum levels of insulin-like growth factor 1 and insulin-like growth factor–binding protein 2 as a novel biomarker in the detection of pancreatic adenocarcinoma

Authors: B Wlodarczyk, A Borkowska, P Wlodarczyk, E Malecka-Panas, …

Journal: Journal of Clinical Gastroenterology

Year: 2020

The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer

Authors: D Campa, M Gentiluomo, A Stein, MN Aoki, M Oliverius, L Vodičková, …

Journal: Critical Reviews in Oncology/Hematology

Year: 2023

The role of insulin-like growth factor (IGF) axis in early diagnosis of pancreatic adenocarcinoma (PDAC)

Authors: B Wlodarczyk, A Gasiorowska, E Malecka-Panas

Journal: Journal of Clinical Gastroenterology

Year: 2018

Dr. Xuefeng Zhang | Innovative Leadership | Best Researcher Award

Posted on by ScienceFather

Dr. Xuefeng Zhang | Innovative Leadership | Best Researcher Award

Liaoning Technical University, China

Profile 

👤 Summary:

Xuefeng Zhang is a Ph.D. student in Civil Engineering and Environment at Liaoning Technical University. His research focuses on high-performance cement-based materials, durability of concrete, and the utilization of industrial solid waste. Xuefeng has contributed to multiple research projects and publications in leading journals and has received numerous awards for his academic excellence.

🎓 Education:

  • Ph.D. in Civil Engineering and Environment (Sep. 2022 – Present)
    Liaoning Technical University, China
    Supervisor: Xiangdong Zhang
  • M.S. in Civil Engineering and Environment (Sep. 2019 – Jul. 2022)
    Liaoning Technical University, China
    Supervisor: Xiangdong Zhang
  • B.S. in Civil Engineering and Environment (Sep. 2015 – Jul. 2019)
    Liaoning Technical University, China

💼 Professional Experience:

  • Involved in multiple projects funded by the National Natural Science Foundation of China, including studies on geotechnical mechanics and material durability.
  • Researcher at the State Key Laboratory of Geotechnical Mechanics and Engineering.

🔬 Research Interests:

  • High-performance cement-based materials
  • Durability of concrete materials
  • Industrial solid waste resource utilization
  • Gob filling material

📜 Selected Publications:

  1. Mechanical properties and microscopic characteristics of fly ash–slag composite backfill (2023).
  2. Study on damage mechanisms in superabsorbent polymer-improved geopolymers (2024).
  3. Multi-scale quantitative characterization of deep coal pores and fissures (2024).

🏅 Awards & Honors:

  • Liaoning Technical University PhD Young Seedling First Prize
  • National First Prize at the China Robot and Artificial Intelligence Competition
  • First-class Scholarship, Liaoning University of Engineering and Technology
  • Provincial First Prize in the Chuanzhi Cup National IT Skills Contest (2023-2024)

 

Notable Publications

Flexural Characteristics of Tailings Cemented with Fiber-Reinforced Green Composite Cementitious Matrix

Authors: Zhang, X., Li, J., Pang, S., Su, L., Liu, J.

Journal: Journal of Materials in Civil Engineering

Year: 2024

Toughening Characteristics of Rubber Granule-Improved Alkali-Activated Slag-Stabilized Aeolian Sand

Authors: Zhang, X., Geng, J., Hu, G., Li, W., Zhang, X.

Journal: Construction and Building Materials

Year: 2024

Failure Mechanism of a Green Substratum Filling Material Based on Digital Scatter Analysis

Authors: Li, J., Zhang, X., Pang, S., Liu, J., Wei, X.

Journal: Construction and Building Materials

Year: 2024

Study of the Damage Mechanism on Mechanical Properties of Super Absorbent Polymer-Improved Geopolymers Under Dry–Wet Cycling

Authors: Zhang, X., Zhang, X., Li, J., Su, L., Liu, J.

Journal: Journal of Materials Science

Year: 2024

Retraction Note: Analysis of Fractured Soft Rock Characteristics in Fault Rupture Zones and Laneway Shoring

Authors: Zhang, X., Zhang, Y., Yang, J., Zhang, X., Fei, E.

Journal: Scientific Reports

Year: 2023

 

Assist Prof Dr. ping she | Innovative Leadership |Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. ping she | Innovative Leadership |Best Researcher Award

Jilin University , China

Profile 

Scopus

🌞Summary 

Ping She is an Assistant Professor at the College of Chemistry, Jilin University, specializing in the application of inorganic porous nanomaterials in photocatalysis. With over 48 published SCI papers and 10 patents (5 of which have been authorized), he has made significant contributions to photocatalytic research. He has been recognized with the 2024 Wiley Wei Li Gao Contribution Author Award and several provincial and national honors for young scientists.

🎓 Education

  • Doctor of Bionic Science and Engineering, College of Biological and Agricultural Engineering, Jilin University (2014-2018)
  • Bachelor of Engineering, Food Science and Engineering, Jilin University (2010-2014)
  • Visiting Scholar, School of Biosystems and Food Science, Zhejiang University (2012)

💼 Professional Experience

  • Assistant Professor, College of Chemistry, Jilin University (2021-present)
  • Postdoctoral Fellow, State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, Jilin University (2018-2021), part of the China Postdoctoral Innovation Talent Program

🔬 Research Interests

Ping She’s research focuses on inorganic semiconductor nanocomposite photocatalysts. His work explores photocatalytic hydrogen evolution, carbon dioxide reduction, and antibacterial applications using bioinspired and nanostructured materials. He continues to push boundaries in clean energy and environmental sustainability.

Notable Publications

Molecular Electrochemical Catalysis of CO-to-Formaldehyde Conversion with a Cobalt Complex

Authors: Singh, A., Zamader, A., Khakpour, R., Busch, M., Robert, M.

Journal: Journal of the American Chemical Society

Year: 2024

Efficient Visible-Light-Driven Carbon Dioxide Reduction using a Bioinspired Nickel Molecular Catalyst

Authors: Zhang, J., She, P., Xu, Q., Bonin, J., Robert, M.

Journal: ChemSusChem

Year: 2024

Single-Layered Imine-Linked Porphyrin-Based Two-Dimensional Covalent Organic Frameworks Targeting CO2 Reduction

Authors: Arisnabarreta, N., Hao, Y., Jin, E., Mali, K.S., De Feyter, S.

Journal: Advanced Energy Materials

Year: 2024

Carbon Nanotube Heterogenization Improves Cobalt Pyridyldiimine Complex CO2 Reduction Activity in Aqueous Carbonate Buffer

Authors: Andrin, B., Marques Cordeiro Junior, P.J., Provost, D., Robert, M., Odobel, F.

Journal: Chemical Communications

Year: 2024

Backbone Engineering of Polymeric Catalysts for High-Performance CO2 Reduction in Bipolar Membrane Zero-Gap Electrolyzer

Authors: Li, G., Huang, L., Wei, C., Robert, M., Ye, R.

Journal: Angewandte Chemie – International Edition

Year: 2024

Dr. Maria Teresa Bonati | Innovative Leadership |Excellence in Leadership and Management Award | 3238

Posted on by ScienceFather

Dr. Maria Teresa Bonati | Innovative Leadership |Excellence in Leadership and Management Award

Institute for Maternal and Child Health “Burlo Garofolo”, Italy

Profile 

Orcid

🌟 Summary

Dr. Maria Teresa Bonati is a dedicated Consultant in Medical Genetics at the Institute for Maternal and Child Health “Burlo Garofolo” in Trieste, Italy. With extensive expertise in neurogenetics and autism spectrum disorders, she has contributed significantly to the field through innovative research and collaboration with esteemed institutions.

🎓 Education

Dr. Bonati holds a Medical Doctor degree and a PhD in Neurology, Psychiatry, and Neurogenetics from the University of Genoa. She is trained in administering ADI-R and ADOS scales for autism diagnosis, with certifications from the Sick Children Hospital in Toronto and Campus Biomedico in Rome.

👩‍⚕️ Professional Experience

Dr. Bonati serves as a Medical Doctor at the Medical Genetics CS of the IRCCS Burlo Garofolo and is a free contract lecturer for the School of Specialization in Medical Genetics. Her experience includes attending the Department of Medical Genetics at Catholic University of Leuven and participating in the European Dysmorphology Group’s annual meetings.

🔬 Research Interests

Dr. Bonati’s research focuses on genetic underpinnings of neurodevelopmental disorders, particularly autism and epilepsy. She has led numerous research projects and published extensively, with notable contributions to the understanding of genetic variants associated with various syndromes and disorders.

📚 Selected Publications

Dr. Bonati’s work has been published in high-impact journals, detailing genetic studies related to conditions such as autosomal dominant nocturnal frontal lobe epilepsy, restless legs syndrome, and autism spectrum disorders. Her citation index reflects her significant impact in the field.

Notable Publications

A Novel KIDINS220 Pathogenic Variant Associated with the Syndromic Spastic Paraplegia SINO: An Expansion of the Brain Malformation Spectrum and a Literature Review

Authors: Maria Teresa Bonati, Cristina Baldoli, Jacopo Taurino, Daniela Marchetti, Lidia Larizza, Palma Finelli, Maria Iascone

Journal: Genes

Year: 2024

Contiguous Gene Syndromes and Hearing Loss: A Clinical Report of Xq21 Deletion and Comprehensive Literature Review

Authors: Maria Teresa Bonati, Agnese Feresin, Paolo Prontera, Paola Michieletto, Valeria Gambacorta, Giampietro Ricci, Eva Orzan

Journal: Genes

Year: 2024

Germline variants in genes of the subcortical maternal complex and Multilocus Imprinting Disturbance are associated with miscarriage/infertility or Beckwith–Wiedemann progeny

Authors: Pierpaola Tannorella, Luciano Calzari, Cecilia Daolio, Ester Mainini, Alessandro Vimercati, Davide Gentilini, Fiorenza Soli, Annalisa Pedrolli, Maria Teresa Bonati, Lidia Larizza et al.

Journal: Clinical Epigenetics

Year: 2022

Challenges and resources in adult life with Joubert syndrome: issues from an international classification of functioning (ICF) perspective

Authors: Romina Romaniello, Chiara Gagliardi, Patrizia Desalvo, Livio Provenzi, Roberta Battini, Enrico Bertini, Maria Teresa Bonati, Marilena Briguglio, Stefano D’Arrigo, Maria Teresa Dotti et al.

Journal: Disability and Rehabilitation

Year: 2022

Identical EP300 variant leading to Rubinstein-Taybi syndrome with different clinical and immunologic phenotype

Authors: Francesco Saettini, Grazia Fazio, Maria Teresa Bonati, Daniele Moratto, Valentina Massa, Elisabetta Di Fede, Silvia Castiglioni, Daniela Marchetti, Marco Chiarini, Alessandra Sottini et al.

Journal: American Journal of Medical Genetics Part A

Year: 2022

 

 

Prof Dr. Shankar Prinja | Strategic Leadership | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Shankar Prinja | Strategic Leadership | Best Researcher Award

Post Graduate Institute of Medical Education and Research, Chandigarh, India 

Profile 

Orcid 

🏫 Early Academic Pursuits

Dr. Shankar Prinja embarked on his academic journey with a strong foundation in medicine. He earned his MBBS degree in 2002 from Gandhi Medical College in Bhopal, Madhya Pradesh, India. His academic excellence was evident early on, as he secured a Gold Medal for achieving first position in Barkatullah University during his Final Part-I MBBS. His passion for preventive and social medicine led him to pursue an MD in Community Medicine at Pt. BD Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India, which he completed in 2005. Further solidifying his expertise, he obtained the Diplomate National Board (DNB) certification in 2006 from the National Board of Examination, New Delhi, India.

Recognizing the importance of health policy and planning in public health, Dr. Prinja expanded his academic horizons internationally. He pursued an MSc in Health Policy, Planning, and Financing in 2009, a joint program between the London School of Hygiene and Tropical Medicine and the London School of Economics and Political Science in the UK. His performance in this rigorous program was exceptional, earning him a distinction from the London School of Economics and Political Science.

💼 Professional Endeavors

Dr. Prinja’s professional career is marked by a deep commitment to health economics and public health. His journey began as a Senior Resident in Community Medicine at the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, where he continued to grow and evolve in various capacities. He quickly progressed from Research Scientist-II (Medical) to Health Economist and then to Assistant Professor of Health Economics.

By 2011, Dr. Prinja was appointed Assistant Professor of Health Economics at PGIMER, and his career trajectory continued to rise. He was promoted to Associate Professor in 2014, Additional Professor in 2017, and eventually Professor of Health Economics in 2021. His role at PGIMER has been instrumental in shaping health policy and economics education in India. He has also served as the Coordinator of the State Training Resource Centre, contributing to the capacity-building of public health professionals.

Dr. Prinja’s expertise has been sought by various national and international organizations. He served as Executive Director at the National Health Authority, Government of India, from January 2022 to January 2023. He has also been a short-term consultant for the World Bank Group on multiple occasions, providing his expertise on health economics and policy.

🧠 Contributions and Research Focus

Dr. Prinja’s research interests lie at the intersection of health economics, policy planning, and financing. His work focuses on improving the efficiency and effectiveness of health systems, particularly in resource-limited settings. He has contributed significantly to the understanding of cost-effectiveness in health interventions, which is crucial for policy formulation in countries like India.

He has been an active member of several technical groups and committees that influence health policy in India. Notably, he is a member of the National Technical Advisory Group on Immunization (NTAGI) and chairs the Vaccine Cost-effectiveness Analysis Sub-group, where his work has been critical in guiding India’s immunization policies. His involvement in the Ministry of Health and Family Welfare’s various task forces, including those on COVID-19 research and the National Health Accounts, highlights his integral role in shaping India’s public health strategies.

Dr. Prinja’s work has had a global impact as well. He is a member of the Technical Group of the COVID-19 Multi-Model Comparison Collaboration (CMCC) of the WHO and World Bank. His research contributions extend to multilateral groups such as the Cost-Effectiveness Data Across Settings (CEDAS) working group of the WHO’s DECIDE Hub.

🏆 Accolades and Recognition

Dr. Prinja’s contributions to public health and health economics have been recognized through numerous prestigious awards and honors. In 2021, he was awarded the Prof MK Seshadri award by the Indian Council of Medical Research, a testament to his impactful research. The same year, he received the Vijay Narain Award from the Indian Association of Preventive and Social Medicine.

Earlier in his career, Dr. Prinja was recognized with the Prof. BC Shrivastav Foundation Award by the Indian Council of Medical Research in 2018. His consistent high-quality research has earned him certificates of appreciation during PGIMER’s Annual Research Day in 2013, 2014, 2018, 2021, 2022, and 2024. Internationally, he was graded ‘A’ (Excellent) at the International Doctoral course in Health Economics and Policy on “Inequalities in Health and Health Care” by the Swiss Schools of Public Health + (SSPH+), Geneva, Switzerland in 2010.

🌍 Impact and Influence

Dr. Prinja’s work has had a profound impact on public health policy and health economics, not just in India but globally. His research has informed critical policy decisions, particularly in the context of immunization and healthcare financing. His role in various advisory boards, including the Tufts-CEVR Global Health Advisory Board and the Health Economics, Management and Policy Program at Newcastle Business School, University of Newcastle, Australia, underscores his influence in the field.

His contributions during the COVID-19 pandemic, particularly through his membership in the WHO and World Bank’s CMCC, were pivotal in guiding global health responses. His work on cost-effectiveness and health system strengthening continues to shape the discourse on sustainable healthcare in developing countries.

🌟 Legacy and Future Contributions

Dr. Shankar Prinja’s legacy is marked by his unwavering commitment to improving public health through rigorous research and impactful policy work. His career has been a blend of academic excellence, professional dedication, and influential research that has left a lasting impact on health systems in India and beyond.

Looking ahead, Dr. Prinja is poised to continue his contributions to global health policy, with a focus on sustainable and equitable healthcare solutions. His ongoing research and involvement in international health economics will undoubtedly continue to shape the future of public health, ensuring that his influence endures for generations to come.

Publications 

Integrating Economic and Health Evidence to Inform Covid-19 Policy in Low- and Middle-Income Countries

Authors: [Not Provided]

Journal: Wellcome Open Research

Year: 2022

What is the Out-of-Pocket Expenditure on Medicines in India? An Empirical Assessment Using a Novel Methodology

Authors: Shankar Prinja

Journal: Health Policy and Planning

Year: 2022

Burden of Group A Streptococcal Pharyngitis, Rheumatic Fever, and Rheumatic Heart Disease in India: A Systematic Review and Meta-Analysis

Authors: Shankar Prinja

Journal: Indian Journal of Pediatrics

Year: 2022

Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women

Authors: Shankar Prinja

Journal: Applied Health Economics and Health Policy

Year: 2022

Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set

Authors: Shankar Prinja

Journal: Value in Health

Year: 2022

 

Dr. Min Pan | Innovative Leadership | Best Researcher Award

Posted on by ScienceFather

Dr. Min Pan | Innovative Leadership | Best Researcher Award

Hong Kong Metropolitan University, Hong Kong

Profile 

Scopus 

🌱 Early Academic Pursuits

Dr. Min PAN, known professionally as Dr. Livia PAN, embarked on her academic journey with a passion for environmental science and soil pollution. She earned her Ph.D. from The Chinese University of Hong Kong, one of the most prestigious institutions in Asia. Her doctoral research laid a solid foundation for her future work, focusing on the intricate dynamics between soil chemistry and environmental pollutants. Her early academic pursuits were marked by an unwavering commitment to understanding and mitigating the impact of human activities on the environment, particularly through the lens of soil science.

🏫 Professional Endeavors

Following the completion of her Ph.D., Dr. PAN joined Hong Kong Metropolitan University as a Senior Lecturer. Her role at the university has allowed her to blend teaching with research, inspiring the next generation of environmental scientists while pushing the boundaries of knowledge in her field. Her teaching philosophy revolves around fostering critical thinking and problem-solving skills in her students, ensuring they are well-equipped to tackle the environmental challenges of the future.

In addition to her teaching responsibilities, Dr. PAN has taken on significant research projects as the Principal Investigator (PI). She has successfully led two Faculty Development Scheme (FDS) projects and two internal projects, securing a total funding of approximately HK$ 2 million. These projects have focused on various aspects of environmental pollution, particularly the interaction between pollutants and soil systems, and have contributed valuable insights into the field.

🔬 Contributions and Research Focus

Dr. PAN’s research is characterized by its interdisciplinary approach, integrating environmental science, soil chemistry, and pollution control. She has a strong focus on the fate and transport of pollutants in the environment, particularly antibiotics and other contaminants in soil and water systems. Her work is essential in understanding how these pollutants move through ecosystems and affect both human health and the environment.

One of her notable research areas is the phytoremediation of contaminated soils, where she explores the use of plants to remove, degrade, or contain harmful pollutants. This research has significant implications for sustainable agriculture and environmental restoration, particularly in regions affected by heavy industrial activities and intensive farming practices.

Her research outputs include 27 papers published in top-tier international journals, all of which are Q1-ranked, and a book chapter that consolidates her expertise in environmental pollution and soil science. Dr. PAN’s work is highly regarded in the scientific community, contributing to our understanding of environmental pollution and offering practical solutions for its mitigation.

🏅 Accolades and Recognition

Dr. PAN’s contributions to environmental science have not gone unnoticed. In 2023, she was recognized by Stanford University as one of the top 2% of the most-cited scientists worldwide, a testament to the impact and relevance of her work. This recognition places her among the global elite in environmental science, highlighting her research’s influence on her field.

Her scientific achievements are further evidenced by her appointment to the editorial boards of several prestigious international journals. These roles allow her to shape the direction of research in environmental science and soil pollution, ensuring that high-quality, impactful research is disseminated to the global scientific community.

🌍 Impact and Influence

Beyond her academic achievements, Dr. PAN’s work has had a tangible impact on environmental policy and practice. Her research on the interaction between soil and pollutants has provided critical insights that have informed environmental management strategies, particularly in the areas of sustainable agriculture and pollution control. Her consultancy work has also enabled her to apply her expertise to real-world challenges, working with industry partners to develop innovative solutions for environmental sustainability.

As a mentor and supervisor, Dr. PAN has guided three MPhil students through their research journeys, imparting her knowledge and fostering their development as independent researchers. Her influence extends beyond her immediate academic environment, inspiring young scientists to pursue careers in environmental science and contribute to solving the pressing environmental issues of our time.

🌟 Legacy and Future Contributions

Looking ahead, Dr. PAN’s future contributions to environmental science are poised to be as impactful as her past work. She continues to push the boundaries of knowledge in her field, with ongoing research projects that promise to yield new insights into the complex interactions between pollutants and the environment.

Her legacy will be one of innovation, leadership, and dedication to environmental sustainability. Through her research, teaching, and mentoring, Dr. PAN is shaping the future of environmental science, leaving an indelible mark on the field and contributing to a more sustainable world for future generations.

📚 Conclusion

Dr. Min PAN, or Dr. Livia PAN as she is known in the academic world, is a distinguished figure in environmental science. Her journey from a passionate Ph.D. student to a globally recognized researcher and educator is a testament to her dedication, expertise, and impact on the field of environmental pollution and soil science. As she continues to lead research initiatives, mentor young scientists, and contribute to environmental sustainability, her work will undoubtedly continue to influence the field and inspire future generations of environmental scientists.

Publications 

Highly porous NiFe-mixed metal oxides derived from calcinated layered double hydroxide for efficient antibiotics removal

    • Authors: Li, Z., Chen, X., Huang, G., Pan, M., Bi, J.
    • Journal: Applied Surface Science
    • Year: 2024

Root chemistry and microbe interactions contribute to metal(loid) tolerance of an aromatic plant – Vetiver grass

    • Authors: Li, H., Rao, Z., Sun, G., Wang, J.-J., Chen, X.W.
    • Journal: Journal of Hazardous Materials
    • Year: 2024

Assessing the Impact of Sewage Sludge-Chinese Medicinal Herbal Residues-Biochar Amendment on Antibiotic Resistance Genes in Soil-Plant Systems

    • Authors: Pan, M., Sham, Y.T.
    • Journal: Journal of Soil Science and Plant Nutrition
    • Year: 2024

Advances in Microfluidic Paper-Based Analytical Devices (µPADs): Design, Fabrication, and Applications

    • Authors: Chen, J.L., Njoku, D.I., Tang, C., Pan, M., Tam, N.F.-Y.
    • Journal: Small Methods
    • Year: 2024

Efficient Hydrogen Peroxide Photosynthesis over CdS/COF for Water Disinfection: The S-Scheme Pathway, Oxygen Adsorption, and Reactor Design

    • Authors: He, Y., Zhao, J., Sham, Y.-T., Wong, P.K., Bi, J.
    • Journal: ACS Sustainable Chemistry and Engineering
    • Year: 2023